4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolid one derivatives as pde-4 inhibitors for the treatment of neurological syndromes

Details for Australian Patent Application No. 2002335015 (hide)

International Classifications

Event Publications

13 February 2003 Complete Application Filed

Priority application(s): 60/329,314 16.10.01 US

3 July 2003 Application Open to Public Inspection

Published as AU-B-2002335015

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

Application withdrawn under section 141(3)/See Reg. 8.3(2). Note that applications or patents shown as lapsed or ceased may be restored at a later date.

2 November 2006 Application Accepted

Published as AU-B-2002335015

30 November 2006 Corrigenda

Applications Accepted - Name Index Under the name Memory Pharmaceuticals Corporation, Application No. 2002335015, under INID (72), correct the co-inventor name to Keuster, Erik

1 March 2007 Standard Patent Sealed

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.